King raises $165mm
Executive Summary
King Pharmaceuticals (acquires and inlicenses branded pharmaceuticals in niche markets) netted $165.5mm in a follow-on offering of 4mm common shares at $41.38 each. All of the shares were purchased by Donaldson, Lufkin, and Jenrette, which will offer them for resale.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice